Fund 1 Proposes Take-Private of Xponential at $5.61-$7.00 Per Share
XPOF sits 26% above its 52-week low of $3.565 on elevated volume (1.9× avg).
Summary
Fund 1 Investments proposed a non-binding cash take-private of Xponential at $5.61-$7.00 per share, at least 50% above the $3.74 close on October 29, while holding roughly 19.9% economic exposure.
Key Events · M&A and Partnerships · XPOF
-
Take-Private Proposal Delivered
Fund 1 sent the board a non-binding proposal to acquire all outstanding Class A shares for $5.61 to $7.00 per share in cash.
-
Premium to Prior Close
The range is at least 50% above the $3.74 closing price on October 29, 2026, versus a $6.76 price on April 6 when the strategic review began.
-
Fund 1 Holds ~19.9% Exposure
Fund 1 reports 4,170,610 shares (~9.9%) plus cash-settled total return swaps on 4,213,826 notional shares (~9.98%).
-
Conditions and Poison Pill Waiver
The bid requires board approval, due diligence and financing, though Fund 1 says definitive agreements would carry no financing condition; it would seek a waiver of the October 12, 2026 Stockholder Rights Agreement.
Analysis · XPOF · Trade & Services
A cash take-private proposal at $5.61-$7.00 per share is now on the table from activist Fund 1, which already holds roughly 19.9% economic exposure. The range sits at least 50% above the $3.74 close on October 29, reframing a stock that has fallen from $6.76 on April 6, when the company began a strategic review, and giving shareholders a concrete floor to weigh against a stalled process. The bid is non-binding and contingent on due diligence, board approval and financing, though Fund 1 says a definitive agreement would carry no financing condition. It also wants the October 12 poison pill waived so other holders can participate. Now the board must respond to a bidder it has publicly described as constructive — a real fork in the road for a leveraged, cash-strapped franchisor.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XPOF was trading at $4.48 on NYSE in the Trade & Services sector, with a market capitalization of approximately $219.7M. The 52-week trading range was $3.57 to $9.25. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.